Related references
Note: Only part of the references are listed.Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
Jason V. Gregory et al.
NATURE COMMUNICATIONS (2020)
Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema
Bangxing Hong et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
Annelise G. Snyder et al.
SCIENCE IMMUNOLOGY (2019)
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells
Annarita Favia et al.
SCIENTIFIC REPORTS (2019)
Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours
Johan Karlsson et al.
NANOSCALE (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma
Shuyu Hao et al.
NEURO-ONCOLOGY (2018)
PRMT5 as a druggable target for glioblastoma therapy
Yeshavanth Kumar Banasavadi-Siddegowda et al.
NEURO-ONCOLOGY (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia
Damian Lai et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression (vol 9, 1047, 2018)
Lingdi Zhang et al.
NATURE COMMUNICATIONS (2018)
Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells
Yan Jia et al.
REDOX BIOLOGY (2018)
PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
Luke Russell et al.
NATURE COMMUNICATIONS (2018)
PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
Y. K. Banasavadi-Siddegowda et al.
ONCOGENE (2017)
Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells
Wen Sun et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
Jaya Sangodkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells
Cuiping Dai et al.
ONCOTARGET (2017)
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
Chao Hu et al.
SCIENTIFIC REPORTS (2017)
Functional importance of PP2A regulatory subunit loss in breast cancer
Lauren F. Watt et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
M. A. Qazi et al.
ANNALS OF ONCOLOGY (2017)
Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options
Godfrey Grech et al.
TUMOR BIOLOGY (2016)
PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells
Winson S. Ho et al.
ONCOTARGET (2016)
Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target
Flavia Radogna et al.
BIOCHEMICAL PHARMACOLOGY (2015)
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential
Christopher S. Hong et al.
CANCER BIOLOGY & THERAPY (2015)
Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment
Chao Zhang et al.
CELL CYCLE (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma
Ira K. Gordon et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
Maria Patrizia Mongiardi et al.
SCIENTIFIC REPORTS (2015)
Exploiting tumor cell senescence in anticancer therapy
Minyoung Lee et al.
BMB REPORTS (2014)
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Fengting Yan et al.
CANCER RESEARCH (2014)
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
Xiaosi Han et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Inside and out: the activities of senescence in cancer
Pedro A. Perez-Mancera et al.
NATURE REVIEWS CANCER (2014)
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Agnieszka Kaczmarek et al.
IMMUNITY (2013)
Protein phosphatase 2A: a target for anticancer therapy
Danilo Perrotti et al.
LANCET ONCOLOGY (2013)
PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells
S. Mannava et al.
ONCOGENE (2012)
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
J. S. Long et al.
ONCOGENE (2012)
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
Nicholas J. Szerlip et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Eaten alive: a history of macroautophagy
Zhifen Yang et al.
NATURE CELL BIOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses
Akihiro Otsuki et al.
MOLECULAR THERAPY (2008)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
J Sage et al.
NATURE (2003)
Role of serine/threonine protein phosphatase 2A in cancer
AH Schönthal
CANCER LETTERS (2001)
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene
R Ruediger et al.
ONCOGENE (2001)
Share Paper
